Literature DB >> 31815689

Screening key lncRNAs with diagnostic and prognostic value for head and neck squamous cell carcinoma based on machine learning and mRNA-lncRNA co-expression network analysis.

Ying Hu1, Geyang Guo1, Junjun Li2, Jie Chen3, Pingqing Tan3.   

Abstract

BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) is the seventh most common type of cancer around the world. The aim of this study was to seek the long non-coding RNAs (lncRNAs) acting as diagnostic and prognostic biomarker of HNSCC.
METHODS: Base on TCGA dataset, the differentially expressed mRNAs (DEmRNAs) and lncRNAs (DElncRNAs) were identified between HNSCC and normal tissue. The machine learning and survival analysis were performed to estimate the potential diagnostic and prognostic value of lncRNAs for HNSCC. We also build the co-expression network and functional annotation. The expression of selected candidate mRNAs and lncRNAs were validated by Quantitative real time polymerase chain reaction (qRT-PCR).
RESULTS: A total of 3363 DEmRNAs (1822 down-regulated and 1541 up-regulated mRNAs) and 32 DElncRNAs (13 down-regulated and 19 up-regulated lncRNAs) between HNSCC and normal tissue were obtained. A total of 13 lncRNAs (IL12A.AS1, RP11.159F24.6, RP11.863P13.3, LINC00941, FOXCUT, RNF144A.AS1, RP11.218E20.3, HCG22, HAGLROS, LINC01615, RP11.351J23.1, AC024592.9 and MIR9.3HG) were defined as optimal diagnostic lncRNAs biomarkers for HNSCC. The area under curve (AUC) of the support vector machine (SVM) model, decision tree model and random forests model and were 0.983, 0.842 and 0.983, and the specificity and sensitivity of the three model were 95.5% and 96.2%, 77.3% and 97.6% and 93.2% and 97.8%, respectively. Among them, AC024592.9, LINC00941, LINC01615 and MIR9-3HG was not only an optimal diagnostic lncRNAs biomarkers, but also related to survival time. The focal adhesion, ECM-receptor interaction, pathways in cancer and cytokine-cytokine receptor interaction were four significantly enriched pathways in DEmRNAs co-expressed with the identified optimal diagnostic lncRNAs. But for most of the selected DEmRNAs and DElncRNAs, the expression was consistent with our integrated analysis results, including LINC00941, LINC01615, FOXCUT, TGA6 and MMP13.
CONCLUSION: AC024592.9, LINC00941, LINC01615 and MIR9-3HG was not only an optimal diagnostic lncRNAs biomarkers, but also were a prognostic lncRNAs biomarkers.

Entities:  

Keywords:  Head and neck squamous cell carcinoma; diagnostic; machine learning; prognostic

Year:  2020        PMID: 31815689     DOI: 10.3233/CBM-190694

Source DB:  PubMed          Journal:  Cancer Biomark        ISSN: 1574-0153            Impact factor:   4.388


  16 in total

1.  LINC01615 activates ZEB2 through competitively binding with miR-3653-3p to promote the carcinogenesis of colon cancer cells.

Authors:  Zhen Hu; Chong Yang; Shangqi Guo; Yiqun Li; Yaoping Li
Journal:  Cell Cycle       Date:  2021-12-29       Impact factor: 4.534

2.  Testing lncRNAs signature as clinical stage-related prognostic markers in gastric cancer progression using TCGA database.

Authors:  Narasimha M Beeraka; Hao Gu; Nannan Xue; Yang Liu; Huiming Yu; Junqi Liu; Kuo Chen; Vladimir N Nikolenko; Ruitai Fan
Journal:  Exp Biol Med (Maywood)       Date:  2022-01-22

3.  A novel molecular-clinicopathologic nomogram to improve prognosis prediction of hepatocellular carcinoma.

Authors:  Zhongjing Zhang; Wanqing Weng; Weiguo Huang; Boda Wu; Yi Zhou; Jie Zhang; Tuo Deng; Wen Ye; Jiecheng Zhang; Jianyang Ao; Qiyu Zhang; Keqing Shi
Journal:  Aging (Albany NY)       Date:  2020-06-30       Impact factor: 5.682

4.  Long noncoding RNA LINC00941 promotes pancreatic cancer progression by competitively binding miR-335-5p to regulate ROCK1-mediated LIMK1/Cofilin-1 signaling.

Authors:  Jie Wang; Zhiwei He; Jian Xu; Peng Chen; Jianxin Jiang
Journal:  Cell Death Dis       Date:  2021-01-04       Impact factor: 8.469

5.  LINC00941 Promotes Progression of Non-Small Cell Lung Cancer by Sponging miR-877-3p to Regulate VEGFA Expression.

Authors:  Min-Huan Ren; Si Chen; Liang-Ge Wang; Wen-Xiu Rui; Pei Li
Journal:  Front Oncol       Date:  2021-03-31       Impact factor: 6.244

6.  Ferroptosis-Related Long Non-Coding RNA Signature Contributes to the Prediction of Prognosis Outcomes in Head and Neck Squamous Cell Carcinomas.

Authors:  Wenru Jiang; Yingtao Song; Zhaowei Zhong; Jili Gao; Xiaofei Meng
Journal:  Front Genet       Date:  2021-12-17       Impact factor: 4.599

7.  Expression changes of serum LINC00941 and LINC00514 in HBV infection-related liver diseases and their potential application values.

Authors:  Juanjuan Chen; Dongling Tang; Huan Li; Pingan Zhang
Journal:  J Clin Lab Anal       Date:  2021-11-26       Impact factor: 2.352

8.  Key genes affecting the progression of nasopharyngeal carcinoma identified by RNA-sequencing and bioinformatic analysis.

Authors:  Yihong Wang; Manyi Li; Yan Guo; Haiping Huang; Xuelin Dong; Yangguang Sun; Jisheng Liu
Journal:  Aging (Albany NY)       Date:  2021-09-20       Impact factor: 5.682

9.  LncRNA RNF144A-AS1 Promotes Bladder Cancer Progression via RNF144A-AS1/miR-455-5p/SOX11 Axis.

Authors:  Huifeng Bi; Zhenhua Shang; Chunsong Jia; Jiangtao Wu; Bo Cui; Qi Wang; Tongwen Ou
Journal:  Onco Targets Ther       Date:  2020-11-04       Impact factor: 4.147

10.  Landscape of associations between long non-coding RNAs and infiltrating immune cells in liver hepatocellular carcinoma.

Authors:  Li Li; Xiaowei Song; Yanju Lv; Qiuying Jiang; Chengjuan Fan; Dayong Huang
Journal:  J Cell Mol Med       Date:  2020-09-10       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.